Europe PCR-Based Transplant Diagnostics Market - Industry Trends and Forecast to 2033

Description

List of Tables

Europe PCR based transplant diagnostics market is expected to reach USD 240,123.15 thousand by 2031, from USD 151,409.28 thousand in 2023 growing at the CAGR of 6.2% in the forecast period of 2024 to 2031.

Market Segmentation

Europe PCR based Transplant Diagnostics Market, By Test Type (CMV PCR Test, EBV PCR Test, BKV PCR Test, VZV PCR Test, HSV1 PCR TestHSV2 PCR Test, Parvovirus B19 PCR Test, P. Jirovecii PCR Test, JCV PCR Test, Adenovirus PCR Test, and Aspergillus Spp PCR Test), By Transplant Type (Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation, Pancreas Transplantation, and Other Transplantations), Application (Diagnostic Applications and Research Applications), End User (Hospitals and Transplant Centers, Commercial Service Providers, Research Laboratories and Academic Institutes), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of the Europe)- Industry Trends and Forecast to 2031

Overview of Europe PCR Based Transplant Diagnostics Market Dynamics

Driver
Increasing prevalence of organ failure
Restraint
Shortage of professionals with expertise in transplant diagnostics
Opportunity
Strategic initiation and technology launches by market players

Market Players

Some of the major market players in Europe PCR based transplant diagnostics market are:

Quest Diagnostics Incorporated.
Eurofins Viracor, LLC

1 INTRODUCTION 14

1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 OVERVIEW OF THE EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET 14
1.4 CURRENCY AND PRICING 15
1.5 LIMITATIONS 15
1.6 MARKETS COVERED 16

2 MARKET SEGMENTATION 18

2.1 MARKETS COVERED 18
2.2 GEOGRAPHICAL SCOPE 19
2.3 YEARS CONSIDERED FOR THE STUDY 20
2.4 DBMR TRIPOD DATA VALIDATION MODEL 21
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 24
2.6 MULTIVARIATE MODELLING 25
2.7 TEST TYPE SEGMENT LIFELINE CURVE 25
2.8 MARKET END USER COVERAGE GRID 26
2.9 DBMR MARKET POSITION GRID 27
2.10 VENDOR SHARE ANALYSIS 28
2.11 SECONDARY SOURCES 29
2.12 ASSUMPTIONS 29

3 EXECUTIVE SUMMARY 30

4 PREMIUM INSIGHTS 32

4.1 PESTAL ANALYSIS 33
4.2 PORTERS FIVE FORCES 34

5 MARKET OVERVIEW 35

5.1 DRIVERS 37
- 5.1.1 INCREASING PREVALENCE OF ORGAN FAILURE 37
- 5.1.2 RISING POPULARITY OF NON-INVASIVE DIAGNOSTIC METHODS 37
- 5.1.3 ADVANCEMENT IN ORGAN PRESERVATIVE TECHNIQUES 38
- 5.1.4 RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES 39
5.2 RESTRAINTS 40
- 5.2.1 SHORTAGE OF PROFESSIONALS WITH EXPERTISE IN TRANSPLANT DIAGNOSTICS 40
- 5.2.2 HIGH COST OF PCR/NGS SOFTWARE 40
5.3 OPPORTUNITIES 41
- 5.3.1 STRATEGIC INITIATION AND TECHNOLOGY LAUNCHES BY MARKET PLAYERS 41
- 5.3.2 RISE IN GOVERNMENT SUPPORT AND FUNDING FOR PCR-BASED ORGAN TRANSPLANTATION 41
- 5.3.3 SURGE OF AWARENESS FOR ORGAN TRANSPLANTATION 42
5.4 CHALLENGES 43
- 5.4.1 ETHICAL CHALLENGES FACED DURING ORGAN TRANSPLANTATION 43
- 5.4.2 LACK OF ORGAN DONORS AND PROVIDERS ANNUALLY 44

6 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE 45

6.1 OVERVIEW 46
6.2 CMV PCR TEST 50
6.3 EBV PCR TEST 50
6.4 BKV PCR TEST 50
6.5 VZV PCR TEST 51
6.6 HSV1 PCR TEST 52
6.7 HSV2 PCR TEST 52
6.8 PARVOVIRUS B19 PCR TEST 52
6.9 P. JIROVECII PCR TEST 53
6.10 JCV PCR TEST 54
6.11 ADENOVIRUS PCR TEST 54
6.12 ASPERGILLUS SPP PCR TEST 55

7 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE 56

7.1 OVERVIEW 57
7.2 KIDNEY TRANSPLANTATION 60
7.3 LIVER TRANSPLANTATION 61
7.4 HEART TRANSPLANTATION 61
7.5 LUNG TRANSPLANTATION 62
7.6 PANCREAS TRANSPLANTATION 62
7.7 OTHER TRANSPLANTATIONS 63

8 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 64

8.1 OVERVIEW 65
8.2 DIAGNOSTIC APPLICATIONS 68
8.3 RESEARCH APPLICATIONS 69

9 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER 70

9.1 OVERVIEW 71
9.2 HOSPITALS AND TRANSPLANT CENTERS 74
9.3 COMMERCIAL SERVICE PROVIDERS 75
9.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 75

10 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 76

10.1 EUROPE 78
- 10.1.1 FRANCE 81
- 10.1.2 U.K. 83
- 10.1.3 SPAIN 85
- 10.1.4 GERMANY 87
- 10.1.5 TURKEY 89
- 10.1.6 ITALY 91
- 10.1.7 RUSSIA 93
- 10.1.8 NETHERLANDS 95
- 10.1.9 BELGIUM 97
- 10.1.10 SWITZERLAND 99
- 10.1.11 REST OF EUROPE 101

11 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, COMPANY LANDSCAPE 102

11.1 COMPANY SHARE ANALYSIS: EUROPE 102

12 SWOT ANALYSIS 103

13 COMPANY PROFILES 104

13.1 QUEST DIAGNOSTICS INCORPORATED. 104
- 13.1.1 COMPANY SNAPSHOT 104
- 13.1.2 REVENUE ANALYSIS 104
- 13.1.3 COMPANY SHARE ANALYSIS 105
- 13.1.4 PRODUCT PORTFOLIO 105
- 13.1.5 RECENT DEVELOPMENTS 106
13.2 LABORATORY CORPORATION OF AMERICA HOLDINGS. 107
- 13.2.1 COMPANY SNAPSHOT 107
- 13.2.2 REVENUE ANALYSIS 107
- 13.2.3 COMPANY SHARE ANALYSIS 108
- 13.2.4 PRODUCT PORTFOLIO 108
- 13.2.5 RECENT DEVELOPMENT 109
13.3 EUROFINS VIRACOR 110
- 13.3.1 COMPANY SNAPSHOT 110
- 13.3.2 COMPANY SHARE ANALYSIS 110
- 13.3.3 PRODUCT PORTFOLIO 111
- 13.3.4 RECENT DEVELOPMENTS 112
13.4 SONIC HEALTHCARE LIMITED 113
- 13.4.1 COMPANY SNAPSHOT 113
- 13.4.2 PRODUCT REVENUE ANALYSIS 113
- 13.4.3 COMPANY SHARE ANALYSIS 114
- 13.4.4 PRODUCT PORTFOLIO 114
- 13.4.5 RECENT DEVELOPMENTS 115
13.5 DR LAL PATHLABS. 116
- 13.5.1 COMPANY SNAPSHOT 116
- 13.5.2 REVENUE ANALYSIS 116
- 13.5.3 COMPANY SHARE ANALYSIS 117
- 13.5.4 PRODUCT PORTFOLIO 117
- 13.5.5 RECENT DEVELOPMENTS 118
13.6 ARUP LABORATORIES 119
- 13.6.1 COMPANY SNAPSHOT 119
- 13.6.2 PRODUCT PORTFOLIO 119
- 13.6.3 RECENT DEVELOPMENT 119
13.7 AMBAR LAB. 120
- 13.7.1 COMPANY SNAPSHOT 120
- 13.7.2 PRODUCT PORTFOLIO 120
- 13.7.3 RECENT DEVELOPMENTS 120

14 QUESTIONNAIRE 121

15 RELATED REPORTS 124

LIST OF TABLES

TABLE 1 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 49
TABLE 2 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 49
TABLE 3 EUROPE CMV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 50
TABLE 4 EUROPE EBV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 50
TABLE 5 EUROPE BKV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 51
TABLE 6 EUROPE VZV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 51
TABLE 7 EUROPE HSV1 PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 52
TABLE 8 EUROPE HSV2 PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 52
TABLE 9 EUROPE PARVOVIRUS B19 PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 53
TABLE 10 EUROPE P. JIROVECII PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 53
TABLE 11 EUROPE JCV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 54
TABLE 12 EUROPE ADENOVIRUS PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 54
TABLE 13 EUROPE ASPERGILLUS SPP PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 55
TABLE 14 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 60
TABLE 15 EUROPE KIDNEY TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 60
TABLE 16 EUROPE LIVER TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 61
TABLE 17 EUROPE HEART TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 61
TABLE 18 EUROPE LUNG TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 62
TABLE 19 EUROPE PANCREAS TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 62
TABLE 20 EUROPE OTHER TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 63
TABLE 21 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 68
TABLE 22 EUROPE DIAGNOSTIC APPLICATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 68
TABLE 23 EUROPE RESEARCH APPLICATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 69
TABLE 24 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 74
TABLE 25 EUROPE HOSPITALS AND TRANSPLANT CENTERS IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 74
TABLE 26 EUROPE COMMERCIAL SERVICE PROVIDERS IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 75
TABLE 27 EUROPE RESEARCH LABORATORIES AND ACADEMIC INSTITUTES IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 75
TABLE 28 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 78
TABLE 29 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 78
TABLE 30 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 79
TABLE 31 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 79
TABLE 32 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 79
TABLE 33 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 80
TABLE 34 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 81
TABLE 35 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 81
TABLE 36 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 82
TABLE 37 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 82
TABLE 38 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 82
TABLE 39 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 83
TABLE 40 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 83
TABLE 41 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 84
TABLE 42 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 84
TABLE 43 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 84
TABLE 44 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 85
TABLE 45 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 85
TABLE 46 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 86
TABLE 47 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 86
TABLE 48 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 86
TABLE 49 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 87
TABLE 50 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 87
TABLE 51 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 88
TABLE 52 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 88
TABLE 53 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 88
TABLE 54 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 89
TABLE 55 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 89
TABLE 56 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 90
TABLE 57 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 90
TABLE 58 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 90
TABLE 59 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 91
TABLE 60 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 91
TABLE 61 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 92
TABLE 62 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 92
TABLE 63 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 92
TABLE 64 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 93
TABLE 65 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 93
TABLE 66 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 94
TABLE 67 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 94
TABLE 68 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 94
TABLE 69 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 95
TABLE 70 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 95
TABLE 71 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 96
TABLE 72 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 96
TABLE 73 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 96
TABLE 74 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 97
TABLE 75 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 97
TABLE 76 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 98
TABLE 77 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 98
TABLE 78 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 98
TABLE 79 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 99
TABLE 80 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 99
TABLE 81 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 100
TABLE 82 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 100
TABLE 83 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 100
TABLE 84 REST OF EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 101
TABLE 85 REST OF EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 101

LIST OF FIGURES

FIGURE 1 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: SEGMENTATION 18
FIGURE 2 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: DATA TRIANGULATION 21
FIGURE 3 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: DROC ANALYSIS 22
FIGURE 4 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: EUROPE VS REGIONAL MARKET SHARE ANALYSIS 23
FIGURE 5 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 23
FIGURE 6 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 24
FIGURE 7 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: MARKET END USER COVERAGE GRID 26
FIGURE 8 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 27
FIGURE 9 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 28
FIGURE 10 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: SEGMENTATION 31
FIGURE 11 INCREASING PREVALENCE OF ORGAN FAILURE IS EXPECTED TO DRIVE THE GROWTH OF THE EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET FROM 2024 TO 2034 32
FIGURE 12 CMV PCR TEST SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET IN 2024 TO 2031 32
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET 36
FIGURE 14 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE, 2023 46
FIGURE 15 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE, 2024-2031 (USD THOUSAND) 47
FIGURE 16 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2024-2031) 47
FIGURE 17 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE LIFELINE CURVE 48
FIGURE 18 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, 2023 57
FIGURE 19 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, 2024-2031 (USD THOUSAND) 58
FIGURE 20 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, CAGR (2024-2031) 58
FIGURE 21 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, LIFELINE CURVE 59
FIGURE 22 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, 2023 65
FIGURE 23 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND) 66
FIGURE 24 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: APPLICATION, CAGR (2024-2031) 66
FIGURE 25 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, LIFELINE CURVE 67
FIGURE 26 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, 2023 71
FIGURE 27 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, 2024-2031 (USD THOUSAND) 72
FIGURE 28 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, CAGR (2024-2031) 72
FIGURE 29 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 73
FIGURE 30 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: SNAPSHOT (2023) 77
FIGURE 31 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: COMPANY SHARE 2023 (%) 102